Showing results (1481-1490 of 1,542) with videos related to

Sort By:
Pageof 155
Ebiomedicine|April 9, 2020
Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progressionTzu-Ting Huang, Ling-Ming Tseng, Ji-Lin Chen, et al.
Obstetrics and Gynecology International|June 12, 2018
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary PerspectiveYeh Chen Lee, Nazlin Jivraj, Catherine O'Brien, et al.
International Journal of Molecular Sciences|December 17, 2011
Enhanced differentiation of three-gene-reprogrammed induced pluripotent stem cells into adipocytes via adenoviral-mediated PGC-1α overexpressionPin-I Huang, Yueh-Ching Chou, Yuh-Lih Chang, et al.
The American Journal of Pathology|September 23, 2022
Deep Learning-Based Nuclear Morphometry Reveals an Independent Prognostic Factor in Mantle Cell LymphomaWen-Yu Chuang, Wei-Hsiang Yu, Yen-Chen Lee, et al.
Protein Expression and Purification|September 4, 2008
One-step isolation of plasma membrane proteins using magnetic beads with immobilized concanavalin AYu-Chen Lee, Gregory Block, Huiwen Chen, et al.
Chemical Research in Toxicology|August 15, 2015
Novel Nrf2/ARE activator, trans-Coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38α/MAPKAPK-2 and PK-N3 signaling pathwayHuang-Hui Chen, Tai-Chi Wang, Yen-Chen Lee, et al.
Journal for Immunotherapy of Cancer|June 9, 2021
Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trialYoland Antill, Peey-Sei Kok, Kristy Robledo, et al.
BMC Surgery|September 16, 2016
Proteinuria can predict prognosis after liver transplantationHeng-Chih Pan, Ying-Jen Chen, Jhe-Ping Lin, et al.
Developmental Cell|June 7, 2017
Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate CancerSong-Chang Lin, Yu-Chen Lee, Guoyu Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2015
Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate CancerAndreas Varkaris, Paul G Corn, Nila U Parikh, et al.
Pageof 155